UofMHealth.org/hht

Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that affects about one in 5,000 to 1 in 10,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12. Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. Learn more about Michigan Medicine’s HHT clinic and our network of physicians who treat HHT patients at UofMHealth.org/hht